EUVIMEDEUVIMED entdecken
Crossref

Deep learning-assisted monitoring of trastuzumab efficacy in HER2-Overexpressing breast cancer via SERS immunoassays of tumor-derived urinary exosomal biomarkers

Jinyoung Kim, Hye Young Son, Sojeong Lee, Hyun Wook Rho, Ryunhyung Kim, Hyein Jeong, Chaewon Park, Byeonggeol Mun, Yesol Moon, Eunji Jeong, Eun-Kyung Lim, Seungjoo Haam

Biosensors and Bioelectronics · 2024

DOI: 10.1016/j.bios.2024.116347 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2024. Verfasst von Jinyoung Kim und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, Yonsei University, Yonsei-ro 50, Seoul, 120-749, Republic of Korea. Hauptthemen laut MEDLINE: Trastuzumab, Exosomes, Erb-b2 Receptor Tyrosine Kinases, Breast Neoplasms. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Korea Environmental Industry and Technology Institute, Korea Ministry of Science and ICT, Korea Research Institute of Bioscience and Biotechnology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monitoring drug efficacy is significant in the current concept of companion diagnostics in metastatic breast cancer. Trastuzumab, a drug targeting human epidermal growth factor receptor 2 (HER2), is an effective treatment for metastatic breast cancer. However, some patients develop resistance to this therapy; therefore, monitoring its efficacy is essential. Here, we describe a deep learning-assisted monitoring of trastuzumab efficacy based on a surface-enhanced Raman spectroscopy (SERS) immunoassay against HER2-overexpressing mouse urinary exosomes. Individual Raman reporters bearing the desired SERS tag and exosome capture substrate were prepared for the SERS immunoassay; SERS tag signals were collected to prepare deep learning training data. Using this deep learning algorithm, various complicated mixtures of SERS tags were successfully quantified and classified. Exosomal antigen levels of five types of cell-derived exosomes were determined using SERS-deep learning analysis and compared with those obtained via quantitative reverse transcription polymerase chain reaction and western blot analysis. Finally, drug efficacy was monitored via SERS-deep learning analysis using urinary exosomes from trastuzumab-treated mice. Use of this monitoring system should allow proactive responses to any treatment-resistant issues.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TrastuzumabExosomesErb-b2 Receptor Tyrosine KinasesBreast NeoplasmsSpectrum Analysis, RamanDeep LearningBiomarkers, TumorBiosensing TechniquesAnimalsFemaleMiceHumansImmunoassayAntineoplastic Agents, Immunological

Stichwörter der Autor:innen

Deep neural networkExosomal antigenHER2-Overexpressing breast cancerSurface enhanced Raman scatteringTrastuzumab efficacy monitoring

Substanzen

TrastuzumabErb-b2 Receptor Tyrosine KinasesBiomarkers, TumorAntineoplastic Agents, ImmunologicalERBB2 protein, human

Autor:innen und Institutionen

  • Department of Chemical and Biomolecular Engineering, Yonsei University, Yonsei-ro 50, Seoul, 120-749, Republic of Korea.
  • Department of Radiology, Yonsei University, Seoul, 03772, Republic of Korea; Severance Biomedical Science Institute, Yonsei University, Seoul, 03772, Republic of Korea; YUHS-KRIBB Medical Convergence Research Institute,…
  • Department of Radiology, Yonsei University, Seoul, 03772, Republic of Korea.
  • Bionanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea; Department of Nanobiotechnology, KRIBB School of Biotechnology, University of Scien…
  • Department of Chemical and Biomolecular Engineering, Yonsei University, Yonsei-ro 50, Seoul, 120-749, Republic of Korea. Electronic address: haam@yonsei.ac.kr.

Förderung

  • Korea Environmental Industry and Technology Institute
  • Korea Ministry of Science and ICT
  • Korea Research Institute of Bioscience and Biotechnology
  • National Research Council of Science and Technology
  • Ministry of Science ICT and Future Planning
  • Ministry of Science, ICT and Future Planning
  • National Research Foundation of Korea
  • Ministry of Education - Singapore

Zitieren

APA

Kim, J., Son, H. Y., Lee, S., Rho, H. W., Kim, R., Jeong, H., Park, C., Mun, B., Moon, Y., Jeong, E., Lim, E. K., & Haam, S. (2024). Deep learning-assisted monitoring of trastuzumab efficacy in HER2-Overexpressing breast cancer via SERS immunoassays of tumor-derived urinary exosomal biomarkers. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2024.116347

Vancouver

Kim J, Son HY, Lee S, Rho HW, Kim R, Jeong H, et al. Deep learning-assisted monitoring of trastuzumab efficacy in HER2-Overexpressing breast cancer via SERS immunoassays of tumor-derived urinary exosomal biomarkers. Biosensors and Bioelectronics. 2024. doi:10.1016/j.bios.2024.116347

BibTeX
@article{Kim2024,
  author = {Kim, Jinyoung and Son, Hye Young and Lee, Sojeong and Rho, Hyun Wook and Kim, Ryunhyung and Jeong, Hyein and Park, Chaewon and Mun, Byeonggeol and Moon, Yesol and Jeong, Eunji and Lim, Eun-Kyung and Haam, Seungjoo},
  title = {Deep learning-assisted monitoring of trastuzumab efficacy in HER2-Overexpressing breast cancer via SERS immunoassays of tumor-derived urinary exosomal biomarkers},
  journal = {Biosensors and Bioelectronics},
  year = {2024},
  doi = {10.1016/j.bios.2024.116347}
}
Kostenlos starten →